• FirefoxInstall the new Firefox »
  •  Dow Up0.04% Nasdaq Up0.33%

    Foundation Medicine, Inc. (FMI)

    47.99 Down 0.07(0.15%) 3:13PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Foundation Medicine, Inc.
    150 Second Street
    Cambridge, MA 02141
    United States - Map
    Phone: 617-418-2200
    Fax: 617-418-2201
    Website: http://www.foundationmedicine.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:293

    Business Summary 

    Foundation Medicine, Inc. provides various molecular information products in the United States. Its molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic information about each patient’s individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted oncology therapies. The company provides clinical products, such as FoundationOne for solid tumors; and FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and myeloma, as well as sarcomas and pediatric cancers. It also offers FoundationCORE, a knowledgebase to publish scientific and medical advances, foster relationships throughout the oncology community, and develop new clinical and technology products. In addition, the company has a strategic collaboration agreement with WuXi PharmaTech Inc. to provide genomic profiles to biopharmaceutical companies conducting clinical trials; and F. Hoffmann-La Roche Ltd. to develop and commercialize molecular information and genomic analysis products for the treatment of cancer patients. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Foundation Medicine, Inc.

    Corporate Governance 
    Foundation Medicine, Inc.’s ISS Governance QuickScore as of Mar 1, 2015 is 10. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 9; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Alexis Borisy A.M., 43
    Co-Founder, Chairman, Chairman of Compensation Committee and Member of Transaction Committee
    Dr. Michael J. Pellini M.D., MBA, 49
    Chief Exec. Officer and Director
    Dr. Steven Kafka Ph.D., 46
    Pres and Chief Operating Officer
    Dr. Vincent A. Miller M.D., 53
    Chief Medical Officer
    Mr. Jason Ryan , 41
    Chief Financial Officer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders